Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 3
2007 2
2008 4
2010 6
2011 4
2012 3
2013 10
2014 5
2015 11
2016 9
2017 8
2018 11
2019 6
2020 8
2021 14
2022 15
2023 7
2024 17
2025 18
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Interlaboratory evaluation of LC-MS-based biomarker assays.
Saito K, Goda R, Arai K, Asahina K, Kawabata M, Uchiyama H, Andou T, Shimizu H, Takahara K, Kakehi M, Yamauchi S, Nitta SI, Suga T, Fujita H, Ishikawa R, Saito Y. Saito K, et al. Bioanalysis. 2024 Mar;16(6):389-402. doi: 10.4155/bio-2023-0173. Epub 2024 Feb 9. Bioanalysis. 2024. PMID: 38334082 Review.
Impact of microsampling on toxicological evaluation in rodent safety studies.
Takahashi K, Hattori N, Yokoyama H, Jinno F, Ohtsuka H, Nakai K, Takumi A, Shibui Y, Yamaguchi K, Shimazaki T, Tanaka Y, Saito K, Kobayashi A, Saito Y. Takahashi K, et al. Among authors: saito k. J Appl Toxicol. 2024 Jan;44(1):118-128. doi: 10.1002/jat.4523. Epub 2023 Aug 7. J Appl Toxicol. 2024. PMID: 37548051 Review.
Current status of Imaging Mass Spectrometry in drug discovery and development: A survey highlighting technical challenges and future directions.
Tanaka Y, Yokoi H, Kaji H, Urasaki Y, Nishidate M, Nitta SI, Watanabe K, Ishida T, Tanaka K, Komatsu R, Yoshida K, Saito K, Saito Y, Yamazaki H. Tanaka Y, et al. Among authors: saito k. Drug Metab Pharmacokinet. 2025 Jun;62:101485. doi: 10.1016/j.dmpk.2025.101485. Epub 2025 Apr 17. Drug Metab Pharmacokinet. 2025. PMID: 40359683 Free article.
Multi-laboratory evaluation of immunoaffinity LC-MS-based glucagon-like peptide-1 assay.
Ishikawa R, Saito K, Tachiki H, Goda R, Arai K, Shimizu H, Andou T, Takahara K, Uchiyama H, Nitta SI, Kakehi M, Hayashi K, Katagiri N, Kojima K, Fujita H, Tsuchinaga K, Saito Y. Ishikawa R, et al. Among authors: saito k. Bioanalysis. 2023 Feb;15(4):207-218. doi: 10.4155/bio-2022-0240. Epub 2023 Mar 24. Bioanalysis. 2023. PMID: 36961372
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Ri M, Iida S, Saito K, Saito Y, Maruyama D, Asano A, Fukuhara S, Tsujimura H, Miyazaki K, Ota S, Fukuhara N, Negoro E, Kuroda J, Yoshida S, Ohtsuka E, Norifumi T, Tabayashi T, Takayama N, Saito T, Suzuki Y, Harada Y, Mizuno I, Yoshida I, Maruta M, Takamatsu Y, Katsuya H, Yoshimitsu M, Minami Y, Kanato K, Munakata W, Nagai H. Ri M, et al. Among authors: saito k. Cancer Chemother Pharmacol. 2025 Jan 24;95(1):29. doi: 10.1007/s00280-025-04752-1. Cancer Chemother Pharmacol. 2025. PMID: 39853402 Clinical Trial.
151 results